NCT03964298View on ClinicalTrials.gov

Study of the Activity of PD-1 Inhibitors in Metastatic Uveal Melanoma

CompletedOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

November 30, 2019

Study Completion Date

December 31, 2020

Conditions

Uveal Melanoma

Trial Locations (1)

75005

Rodrigues, Paris

All Listed Sponsors

lead

Institut Curie

OTHER

NCT03964298 - Study of the Activity of PD-1 Inhibitors in Metastatic Uveal Melanoma | Biotech Hunter | Biotech Hunter